Last reviewed · How we verify

chitosan gel

Ain Shams University · FDA-approved active Small molecule

Chitosan gel acts as a biopolymer scaffold that promotes hemostasis, wound healing, and tissue regeneration through its mucoadhesive and antimicrobial properties.

Chitosan gel acts as a biopolymer scaffold that promotes hemostasis, wound healing, and tissue regeneration through its mucoadhesive and antimicrobial properties. Used for Wound healing and hemostasis, Topical wound management.

At a glance

Generic namechitosan gel
Also known asCS, polymers, hydroxyapatite hydrogel, miconaz oral gel
SponsorAin Shams University
Drug classBiopolymer wound dressing / hemostatic agent
ModalitySmall molecule
Therapeutic areaWound Care / Dermatology
PhaseFDA-approved

Mechanism of action

Chitosan is a natural polysaccharide derived from chitin that forms a gel matrix capable of absorbing wound exudate, promoting blood clotting, and creating a moist healing environment. Its positive charge allows it to interact with negatively charged cell membranes and bacterial surfaces, providing antimicrobial activity. The gel also facilitates cell proliferation and angiogenesis, supporting tissue repair and regeneration.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: